{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:31Z","timestamp":1792181731156,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012262","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000}}],"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["971510"],"award-info":[{"award-number":["971510"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_15040"],"award-info":[{"award-number":["MC_PC_15040"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Horizon 2020 Research and Innovation Program","award":["824061"],"award-info":[{"award-number":["824061"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Viral haemorrhagic fevers (VHF) pose a significant threat to human health. In recent years, VHF outbreaks caused by Ebola, Marburg and Lassa viruses have caused substantial morbidity and mortality in West and Central Africa. In 2022, an Ebola disease outbreak in Uganda caused by Sudan virus resulted in 164 cases with 55 deaths. In 2023, a Marburg disease outbreak was confirmed in Equatorial Guinea and Tanzania resulting in over 49 confirmed or suspected cases; 41 of which were fatal. There are no clearly defined correlates of protection against these VHF, impeding targeted vaccine development. Any vaccine developed should therefore induce strong and preferably long-lasting humoral and cellular immunity against these viruses. Ideally this immunity should also cross-protect against viral variants, which are known to circulate in animal reservoirs and cause human disease. We have utilized two viral vectored vaccine platforms, an adenovirus (ChAdOx1) and Modified Vaccinia Ankara (MVA), to develop a multi-pathogen vaccine regime against three filoviruses (Ebola virus, Sudan virus, Marburg virus) and an arenavirus (Lassa virus). These platform technologies have consistently demonstrated the capability to induce robust cellular and humoral antigen-specific immunity in humans, most recently in the rollout of the licensed ChAdOx1-nCoV19\/AZD1222. Here, we show that our multi-pathogen vaccines elicit strong cellular and humoral immunity, induce a diverse range of chemokines and cytokines, and most importantly, confers protection after lethal Ebola virus, Sudan virus and Marburg virus challenges in a small animal model.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012262","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T17:48:59Z","timestamp":1719424139000},"page":"e1012262","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse"],"prefix":"10.1371","volume":"20","author":[{"given":"Amy","family":"Flaxman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Appelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan M.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ulaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi","family":"Purushotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagida","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-1838","authenticated-orcid":true,"given":"Daniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Dowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Easterbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Findlay-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirazimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-897X","authenticated-orcid":true,"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"issue":"1","key":"ppat.1012262.ref001","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview.","volume":"44","author":"O Ogbu","year":"2007","journal-title":"J Vector Borne Dis"},{"key":"ppat.1012262.ref002","author":"K. Kerlin","year":"2018","journal-title":"Deadly Marburg Virus Found in Sierra Leone Bats: Human & Animal Health"},{"issue":"5","key":"ppat.1012262.ref003","doi-asserted-by":"crossref","first-page":"e1002300","DOI":"10.1371\/journal.pmed.1002300","article-title":"Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014\u20132016: A cross-sectional study.","volume":"14","author":"CF Houlihan","year":"2017","journal-title":"PLoS Med."},{"issue":"10113","key":"ppat.1012262.ref004","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/S0140-6736(17)32092-5","article-title":"Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis","volume":"390","author":"DM Pigott","year":"2017","journal-title":"Lancet"},{"key":"ppat.1012262.ref005","volume-title":"Democratic Republic of the Congo","author":"Ebola situation reports","year":"2018"},{"issue":"18","key":"ppat.1012262.ref006","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa1804498","article-title":"Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018","volume":"379","author":"KJ Siddle","year":"2018","journal-title":"N Engl J Med"},{"issue":"10068","key":"ppat.1012262.ref007","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!).","volume":"389","author":"AM Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"ppat.1012262.ref008","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2666-5247(23)00001-0","article-title":"Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques","volume":"4","author":"A Marzi","year":"2023","journal-title":"Lancet Microbe"},{"key":"ppat.1012262.ref009","article-title":"Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine","volume":"89","author":"KL O\u2019Donnell","year":"2023","journal-title":"eBioMedicine"},{"issue":"6","key":"ppat.1012262.ref010","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"TW Geisbert","year":"2005","journal-title":"PLoS Med"},{"issue":"4","key":"ppat.1012262.ref011","doi-asserted-by":"crossref","first-page":"e0003736","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"D Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"17","key":"ppat.1012262.ref012","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA","volume":"374","author":"K Ewer","year":"2016","journal-title":"The New England journal of medicine"},{"issue":"7","key":"ppat.1012262.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.","volume":"7","author":"MD Dicks","year":"2012","journal-title":"PloS one."},{"issue":"2","key":"ppat.1012262.ref014","doi-asserted-by":"crossref","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).","volume":"3","author":"MG Cottingham","year":"2008","journal-title":"PLoS One."},{"key":"ppat.1012262.ref015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-6869-5_6","article-title":"Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.","volume":"1581","author":"V Pavot","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"5","key":"ppat.1012262.ref016","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.1101004","article-title":"The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus","volume":"187","author":"SC de Cassan","year":"2011","journal-title":"J Immunol"},{"issue":"7","key":"ppat.1012262.ref017","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine","volume":"43","author":"CE Mullarkey","year":"2013","journal-title":"Eur J Immunol"},{"key":"ppat.1012262.ref018","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.","volume":"3","author":"T Lambe","year":"2013","journal-title":"Sci Rep."},{"issue":"6","key":"ppat.1012262.ref019","article-title":"Reidentification of Ebola Virus E718 and ME as Ebola Virus\/H.sapiens-tc\/COD\/1976\/Yambuku-Ecran.","volume":"2","author":"JH Kuhn","year":"2014","journal-title":"Genome Announc"},{"issue":"11","key":"ppat.1012262.ref020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s13059-014-0540-x","article-title":"Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity","volume":"15","author":"SD Dowall","year":"2014","journal-title":"Genome Biol"},{"key":"ppat.1012262.ref021","article-title":"Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge","author":"CM Tully","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1012262.ref022","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"A Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"issue":"10","key":"ppat.1012262.ref023","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3390\/v7102892","article-title":"The Role of Cytokines and Chemokines in Filovirus Infection.","volume":"7","author":"SL Bixler","year":"2015","journal-title":"Viruses"},{"issue":"6","key":"ppat.1012262.ref024","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.06284-11","article-title":"Functional interferon system is required for clearance of lassa virus","volume":"86","author":"NE Yun","year":"2012","journal-title":"Journal of virology"},{"issue":"8","key":"ppat.1012262.ref025","doi-asserted-by":"crossref","first-page":"e72290","DOI":"10.1371\/journal.pone.0072290","article-title":"Infection of Type I Interferon Receptor-Deficient Mice with Various Old World Arenaviruses: A Model for Studying Virulence and Host Species Barriers.","volume":"8","author":"T Rieger","year":"2013","journal-title":"PLOS ONE."},{"key":"ppat.1012262.ref026","doi-asserted-by":"crossref","first-page":"25280","DOI":"10.1038\/srep25280","article-title":"New Hosts of The Lassa Virus.","volume":"6","author":"A Olayemi","year":"2016","journal-title":"Sci Rep."},{"issue":"7","key":"ppat.1012262.ref027","doi-asserted-by":"crossref","first-page":"e1000536","DOI":"10.1371\/journal.ppat.1000536","article-title":"Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.","volume":"5","author":"JS Towner","year":"2009","journal-title":"PLoS Pathog."},{"issue":"suppl_5","key":"ppat.1012262.ref028","first-page":"S312","article-title":"Seroprevalence of Filovirus Infection of Rousettus aegyptiacus Bats in Zambia","volume":"218","author":"K Changula","year":"2018","journal-title":"J Infect Dis"},{"key":"ppat.1012262.ref029","doi-asserted-by":"crossref","first-page":"1178122x19849927","DOI":"10.1177\/1178122X19849927","article-title":"Filovirus Disease Outbreaks: A Chronological Overview","volume":"10","author":"S Languon","year":"2019","journal-title":"Virology (Auckl)."},{"key":"ppat.1012262.ref030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-018-0049-5","article-title":"Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.","volume":"3","author":"HJ Hallam","year":"2018","journal-title":"NPJ Vaccines."},{"issue":"4","key":"ppat.1012262.ref031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"S Baize","year":"1999","journal-title":"Nat Med"},{"issue":"24","key":"ppat.1012262.ref032","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"S Mulangu","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"ppat.1012262.ref033","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-020-00261-9","article-title":"Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate","volume":"5","author":"R Roozendaal","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ppat.1012262.ref034","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2015.00367","article-title":"Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines.","volume":"6","author":"G Grodeland","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"ppat.1012262.ref035","article-title":"T-Cell Response to Viral Hemorrhagic Fevers.","volume":"7","author":"F Perdomo-Celis","year":"2019","journal-title":"Vaccines (Basel)."},{"issue":"10","key":"ppat.1012262.ref036","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"key":"ppat.1012262.ref037","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coi.2015.06.006","article-title":"Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.","volume":"35","author":"Y Zhou","year":"2015","journal-title":"Current opinion in immunology."},{"issue":"9","key":"ppat.1012262.ref038","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"NJ Sullivan","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"ppat.1012262.ref039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-021-00291-x","article-title":"ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge","volume":"6","author":"RJ Fischer","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ppat.1012262.ref040","first-page":"2023.10.20.563337","volume-title":"A bivalent Adenovirus-Vectored Vaccine induces a measurable humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus.","author":"Tol Sv","year":"2023"},{"issue":"3","key":"ppat.1012262.ref041","first-page":"253","article-title":"Animal Models of Ebolavirus Infection.","volume":"67","author":"MC St Claire","year":"2017","journal-title":"Comp Med."},{"issue":"Suppl 2","key":"ppat.1012262.ref042","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1093\/infdis\/jiv126","article-title":"A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs","volume":"212","author":"CE Mire","year":"2015","journal-title":"J Infect Dis"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012262","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T20:24:20Z","timestamp":1732307060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012262"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Marzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012262","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1012262","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}